Gyre Therapeutics, Inc. (GYRE)
NASDAQ: GYRE · Real-Time Price · USD
6.07
-0.22 (-3.50%)
Jun 8, 2026, 3:41 PM EDT - Market open
Gyre Therapeutics Market Cap
Gyre Therapeutics has a market cap or net worth of $554.63 million as of June 8, 2026. Its market cap has decreased by -39.29% in one year.
Market Cap
554.63M
Enterprise Value
496.51M
1-Year Change
-39.29%
Ranking
Category
Stock Price
$6.07
Market Cap Chart
Since October 31, 2023, Gyre Therapeutics's market cap has increased from $515.41M to $554.63M, an increase of 7.61%. That is a compound annual growth rate of 2.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2026 | 574.73M | -10.43% |
| Dec 31, 2025 | 641.69M | -38.21% |
| Dec 31, 2024 | 1.04B | -47.22% |
| Dec 29, 2023 | 1.97B | 281.72% |
| Oct 31, 2023 | 515.41M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aclaris Therapeutics | 608.93M |
| Crescent Biopharma | 598.12M |
| First Tracks Biotherapeutics | 579.21M |
| MiMedx Group | 557.06M |
| Rigel Pharmaceuticals | 553.77M |
| Immix Biopharma | 553.44M |
| Prime Medicine | 552.69M |
| Tectonic Therapeutic | 547.21M |